NCT04855240View on ClinicalTrials.gov

Evaluate the Efficacy and Safety of ACP-044 for the Treatment of Acute Postoperative Pain Following Bunionectomy

PHASE2CompletedINTERVENTIONAL
Enrollment

239

Participants

Timeline

Start Date

March 29, 2021

Primary Completion Date

February 11, 2022

Study Completion Date

March 14, 2022

Conditions
Acute Postoperative PainBunionectomy
Interventions
DRUG

ACP-044 Dose A

Oral dose of ACP-044 Dose A

DRUG

ACP-044 Dose B

Oral dose of ACP-044 Dose B

DRUG

Placebo

Oral dose of placebo

Trial Locations (4)

21122

Chesapeake Ambulatory Surgery Center, Pasadena

78229

Endeavor Clinical Trials of San Antonio, TX, San Antonio

84107

JBR Cinical Research, Salt Lake City

92801

Anaheim Clinical Trials, Anaheim

Sponsors
All Listed Sponsors
lead

ACADIA Pharmaceuticals Inc.

INDUSTRY